Expression of CRISPR/Cas single guide RNAs using small tRNA promoters

RNA

Volumn 21, Issue 9, 2015, Pages 1683-1689

  Mefferd, Adam L ^a   Kornepati, Anand V R ^a   Bogerd, Hal P ^a   Kennedy, Edward M ^a   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CRISPR Cas; Gene editing; TRNA processing; TRNase Z

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; GUIDE RNA; TRANSFER RNA; CRISPR ASSOCIATED PROTEIN; VIRUS RNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CRISPR CAS SYSTEM; DNA SEQUENCE; GENE EXPRESSION; GENETIC CODE; HUMAN PAPILLOMAVIRUS TYPE 18; MOLECULE; NEISSERIA MENINGITIDIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; STREPTOCOCCUS PYOGENES; ANIMAL; GENETIC ENGINEERING; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS;

ADENO-ASSOCIATED VIRUS; STREPTOCOCCUS PYOGENES;

ANIMALS; CRISPR-ASSOCIATED PROTEINS; GENETIC ENGINEERING; HEK293 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; RNA, GUIDE; RNA, TRANSFER; RNA, VIRAL; SEQUENCE ANALYSIS, RNA;

EID: 84939810653     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.051631.115     Document Type: Article

References (26)

1. Bogerd HP, Karnowski HW, Cai X, Shin J, Pohlers M, Cullen BR. 2010.A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral microRNAs. Mol Cell 37: 135-142.
2. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
3. Cox DB, Platt RJ, Zhang F. 2015. Therapeutic genome editing: prospects and challenges. Nat Med 21: 121-131.
4. Cullen BR. 1987. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152: 684-704.
5. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. 2013. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 10: 1116-1121.
6. Flores O, Kennedy EM, Skalsky RL, Cullen BR. 2014. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res 42: 4629-4639.
7. Frock RL, Hu J, Meyers RM, Ho YJ, Kii E, Alt FW. 2015. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol 33: 179-186.
8. Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, Thomson JA. 2013. Efficient genome engineering in human pluri-potent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci 110: 15644-15649.
9. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-1278.
10. Kennedy EM, Kornepati AV, Goldstein M, Bogerd HP, Poling BC, Whisnant AW, Kastan MB, Cullen BR. 2014. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. J Virol 88: 11965-11972.
11. Kennedy EM, Bassit LC, Mueller H, Kornepati AVR, Bogerd HP, Nie T, Chatterjee P, Javanbakht H, Schinazi RF, Cullen BR. 2015. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endo-nuclease. Virology 476: 196-205.
12. Kotterman MA, Schaffer DV. 2014. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet 15: 445-451.
13. Kozomara A, Griffiths-Jones S. 2014. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42: D68-D73.
14. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
15. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. 2013a. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31: 833-838.
16. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013b. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
17. Mituyama T, Yamada K, Hattori E, Okida H, Ono Y, Terai G, Yoshizawa A, Komori T, Asai K. 2009. The functional RNA database 3.0: databases to support mining and annotation of functional RNAs. Nucleic Acids Res 37: D89-D92.
18. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, et al. 2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-1389.
19. Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, et al. 2015. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520: 186-191.
20. Sanjana NE, Shalem O, Zhang F. 2014. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11: 783-784.
21. Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, Sur M, Zhang F. 2015. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 33: 102-106.
22. Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, et al. 2015. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33: 187-197.
23. Waldron C, Lacroute F. 1975. Effect of growth rate on the amounts of ribosomal and transfer ribonucleic acids in yeast. J Bacteriol 122: 855-865.
24. Wang X, Wang Y, Wu X, Wang J, Wang Y, Qiu Z, Chang T, Huang H, Lin RJ, Yee JK. 2015. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33: 175-178.
25. Xie K, Minkenberg B, Yang Y. 2015. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci 112: 3570-3575.
26. Zhang Y, Heidrich N, Ampattu BJ, Gunderson CW, Seifert HS, Schoen C, Vogel J, Sontheimer EJ. 2013. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol Cell 50: 488-503.